Eating Well, Healing Better: The Role of Integrative Colorectal Cancer Treatment in Improving Quality of Life During Care

Colorectal cancer treatment has become increasingly effective in recent decades, with advances in surgical technique, chemotherapy protocols, targeted therapies, and immunotherapy producing meaningfully improved survival for patients across stages. But survival is not the only measure of successful cancer care. Quality of life during and after treatment matters profoundly, and it is an area where integrative oncology has a specific, valuable, and evidence-based contribution to make.

Dr. Jonathan Stegall at The Center for Advanced Medicine brings integrative oncology expertise to colorectal cancer patients alongside their conventional care teams. The focus is not on replacing any aspect of established colorectal cancer treatment. It is on supporting the patient as a whole person through a process that places significant physical and psychological demands on them and on ensuring that the biological environment supports both treatment efficacy and recovery.

The Conventional Treatment Landscape for Colorectal Cancer

Colorectal cancer treatment depends on disease stage and location. Surgery is the primary treatment for localized colorectal cancer and involves resection of the tumor-bearing segment of the colon or rectum. For colon cancer, this is typically performed laparoscopically with good surgical outcomes. For rectal cancer, the surgical approach is more complex and may involve permanent or temporary ostomy depending on the tumor location and the extent of surgery required.

Chemotherapy is used in the adjuvant setting for stage III colon cancer and for stage II patients with high-risk features to reduce the risk of recurrence after surgery. The standard adjuvant regimens include FOLFOX and CAPOX. For metastatic colorectal cancer, chemotherapy is used in combination with targeted agents including bevacizumab and anti-EGFR antibodies such as cetuximab and panitumumab in tumors with wild-type RAS. Immunotherapy with checkpoint inhibitors is highly effective in the subset of patients whose tumors have microsatellite instability-high status, which occurs in approximately 5 percent of metastatic colorectal cancers.

Nutrition and Colorectal Cancer: A Uniquely Important Relationship

The relationship between nutrition and colorectal health is particularly direct. The colon is the organ through which food residue passes, and the dietary environment of the colon influences its microbiome, its inflammatory state, and its cancer risk. This relationship continues to be relevant after a colorectal cancer diagnosis and through treatment.

Patients who have had colon or rectal surgery often experience significant changes in bowel function and diet tolerance during the recovery period. Managing these changes with appropriate dietary guidance supports physical recovery and reduces the distress associated with unpredictable bowel function. Dr. Stegall provides specific guidance for post-surgical dietary adjustment that is calibrated to the type of surgery performed and the patient’s individual recovery trajectory.

During chemotherapy, colorectal cancer patients commonly experience nausea, diarrhea, mucositis, fatigue, and appetite changes. Each of these affects nutritional intake and the body’s ability to maintain the energy and protein status required for immune function and tissue repair. Practical strategies for managing these symptoms nutritionally, alongside appropriate antiemetic and antidiarrheal medications, help patients maintain better nutritional status through treatment.

An anti-inflammatory, plant-rich dietary pattern has evidence for reducing the risk of colorectal cancer recurrence in survivors and is the foundation of Dr. Stegall’s nutritional recommendations. Research on colorectal cancer survivors has demonstrated that higher intake of plant foods, lower intake of red and processed meats, and higher fiber consumption are associated with reduced recurrence risk and improved overall survival.

The Gut Microbiome and Colorectal Cancer Recovery

The gut microbiome, the community of trillions of bacteria and other microorganisms inhabiting the gastrointestinal tract, plays a significant role in colorectal cancer and its treatment. The microbiome influences local immune function in the gut, modulates systemic inflammation, affects the metabolism of certain chemotherapy drugs, and appears to influence the response to immunotherapy in microsatellite instability-high colorectal cancers.

Colorectal surgery, antibiotics used perioperatively, and chemotherapy all disrupt the microbiome in ways that may impair recovery and treatment response. Supporting microbiome restoration through dietary means, including fermented foods, prebiotic fiber, and in some cases specific probiotic supplementation, is a component of Dr. Stegall’s integrative approach to colorectal cancer care.

The evidence base for specific probiotic supplementation during colorectal cancer treatment is developing, and Dr. Stegall approaches this area with the nuance it requires, distinguishing between what the research currently supports and where clinical judgment must fill the gaps.

Physical Activity and Exercise

The evidence for exercise in colorectal cancer survivors is among the strongest in oncology. Studies have consistently demonstrated that physically active colorectal cancer survivors have lower recurrence rates and better overall survival than sedentary survivors, with some analyses suggesting reductions in recurrence risk of 30 to 40 percent among the most active patients.

The mechanisms are multiple: exercise reduces systemic inflammation, improves insulin sensitivity, supports immune surveillance, and reduces the circulating levels of growth factors that promote tumor cell proliferation. Resistance exercise additionally preserves muscle mass, which is independently associated with better treatment tolerance and survival in cancer patients.

Dr. Stegall integrates exercise recommendations into the care plans of colorectal cancer patients with guidance that is specific to each patient’s surgical recovery status, current treatment phase, and physical capacity.

Emotional and Psychological Support

Colorectal cancer diagnosis and treatment involve unique psychological burdens including anxiety about recurrence, body image concerns related to ostomy, sexual dysfunction related to pelvic surgery, and the long-term adjustment to changes in bowel function that may persist after treatment. These concerns are not incidental. They significantly affect quality of life and deserve the same clinical attention as physical symptoms.

Dr. Stegall addresses the psychological dimension of colorectal cancer care directly, incorporating referrals to appropriate support resources and mind-body practices that have evidence for reducing cancer-related distress.

Contact The Center for Advanced Medicine to schedule a consultation with Dr. Jonathan Stegall and learn how integrative care can improve your quality of life during colorectal cancer treatment.